glp-1 suicide and suicide attempt in users of receptor agonists: a nationwide case-time-control study Ozempic, Wegovy Under Investigation for

Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization

Simonsen E, Lund LC, Ernst MT, et al

Unfortunately, not everyone is a good candidate for these medications

Understanding the mechanisms underpinning these effects is also important, as it may provide additional information on the cross-talk between cannabinoids and physiological pathways that regulate appetite and metabolism

Participants underwent regular monitoring including adverse event tracking

Immunohistochemistry Immunohistochemistry for calcitonin, synaptophysin, insulin, glucagon, somatostatin, and pancreatic polypeptide (PP) was performed on formalin-fixed tissues